Evidence map›Paper›PMID 31321245›Full record

ArticleJournal of immunology research2019

Ying Tang, Sanda A Tan, Atif Iqbal, Jian Li, Sarah C Glover

Open access · goldAbstract read
In one paragraph

Article in Journal of immunology research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 13 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. ILC3: a case of conflicted identity.Frontiers in immunology · 2023
    Review
  8. Article
  9. Article
  10. Review
  11. Innate Lymphoid Cells in Crohn's Disease.Frontiers in immunology · 2020
    Review
  12. Novel Association betweenIndian journal of dermatology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Ying TangDepartment of Medicine, University of Florida, Gainesville, FL 32610, USA.ORCID https://orcid.org/0000-0003-4357-2343
Sanda A TanDepartment of Surgery, University of Florida, Gainesville, FL 32610, USA.ORCID https://orcid.org/0000-0002-3462-4503
Atif IqbalDepartment of Surgery, Baylor College of Medicine, Houston, TX 77030, USA.
Jian LiDepartment of Neurology, Thomas Jefferson University, Philadelphia, PA 19107, USA.
Sarah C GloverDepartment of Medicine, University of Florida, Gainesville, FL 32610, USA.ORCID https://orcid.org/0000-0002-9899-0473
University of Florida · USBaylor College of Medicine · USThomas Jefferson University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Crohn's disease (CD) results from dysregulated immune responses to gut microbiota in genetically susceptible individuals, affecting multiple areas of the gastrointestinal tract. Innate lymphoid cells (ILCs) are tissue-resident innate effector lymphocytes which play crucial roles in mucosal immune defense, tissue repair, and maintenance of homeostasis. The accumulation of IFN-

Indexed as

Crohn DiseaseDisease ProgressionHumansIleumImmunity, InnateInflammationInterleukin-23LymphocytesNatural Cytotoxicity Triggering Receptor 2PhosphorylationProto-Oncogene Proteins c-kitSTAT3 Transcription FactorTyrosineInterleukin-23KIT protein, humanNatural Cytotoxicity Triggering Receptor 2NCR2 protein, humanProto-Oncogene Proteins c-kitSTAT3 protein, humanSTAT3 Transcription FactorTyrosine

Identifiers

PMID31321245
PMCPMC6610725
OpenAlexW2950868254

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.